Alivus Life Sciences Ltd
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 |
|---|---|---|---|
| Revenue | 701.90 | 662.82 | 711.90 |
| Operating Expense | 416.80 | 428.70 | 474.59 |
| Net Profit | 196.75 | 160.08 | 162.66 |
| Net Profit Margin | 28.03% | 24.15% | 22.85% |
| Earning Per Share | 16.02 | 13.04 | 13.23 |
| EBIDTA | 280.46 | 232.25 | 235.26 |
| Effective Tax Rate | 21.25% | 21.47% | 21.53% |
Particulars
Sep 2026
Revenue701.90
Operating Expense416.80
Net Profit196.75
Net Profit Margin28.03
Earning Per Share16.02
EBIDTA280.46
Effective Tax Rate21.25
